Huntington's Disease with Small CAG Repeat Expansions

被引:2
|
作者
Heinzmann, Anna [1 ,2 ]
Sayah, Sabrina [2 ]
Lejeune, Francois-Xavier [1 ,3 ]
Hahn, Valerie [4 ]
Teichmann, Marc [5 ]
Monin, Marie-Lorraine [6 ]
Marchionni, Enrica [7 ]
Gerard, Fleur [8 ]
Charles, Perrine [1 ]
Pariente, Jeremie [8 ,9 ]
Durr, Alexandra [1 ,2 ,10 ]
机构
[1] Sorbonne Univ, AP HP, CRNS, INSERM,ICM Inst Cerveau,Paris Brain Inst, Paris, France
[2] AP HP, Reference Ctr Rare Dis Neurogenet, Paris, France
[3] Pitie Salpetriere Sorbonne Univ Hosp, Paris Brain Inst Data Anal Core, Paris, France
[4] GHU Paris Psychiat & Neurosci, Hop Sainte Anne, Dept Neurol Memory & Language, Paris, France
[5] Pitie Salpetriere Sorbonne Univ Hosp, Neurol Dept, Paris, France
[6] Bordeaux Univ Hosp, Genet Dept, Bordeaux, France
[7] Tor Vergata Univ Hosp, Med Genet, Rome, Italy
[8] CHU Toulouse, Hop Purpan, Neurol Dept, Toulouse, France
[9] Univ Toulouse Paul Sabatier, Toulouse NeuroImaging Ctr ToNIC, INSERM, Toulouse, France
[10] ICM 47 bd lHop, F-75013 Paris, France
关键词
chorea; cognitive decline; Huntington's disease; reduced penetrance; small expansions; CEREBRAL-CORTEX; ONSET; PROGRESSION; PENETRANCE; ALLELES; RISK; AGE;
D O I
10.1002/mds.29427
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundCarriers of small cytosine-adenine-guanine (CAG) repeats below 39 in the HTT gene are traditionally associated with milder Huntington's disease, but their clinical profile has not been extensively studied. ObjectiveTo study the phenotype of CAG(36-38) repeat carriers. MethodsWe included 35 patients and premanifest carriers of CAG(36-38) repeats. We compared clinical and neuropsychological profiles of 11 CAG(36-38) patients with 11 matched CAG(40-42) patients. In addition, we analyzed 243 CAG(36-38) individuals from the ENROLL study to complete the phenotype description. ResultsGlobal cognitive efficiency and performance in different cognitive subdomains were similar in small CAG(36-38) and typically CAG(40-42) expanded individuals. Chorea as the first symptom was significantly less frequent for CAG(36-38) patients (P = 0.04) despite similar total motor scores at first visit. Total motor score at last visit was significantly lower in CAG(36-38) carriers (P = 0.003). The similar cognitive and different motor profile of CAG(36-38) (n = 243) and CAG(40-42) (n = 4675) carriers was confirmed in the ENROLL database. Additionally, clinicians were significantly less confident in diagnosing Huntington's disease (P = 2.4e-8) and diagnosis happened significantly later in CAG(36-38) (P = 2.2e-6) despite a similar age at symptom onset (P = 0.29). ConclusionsWe showed that small CAG(36-38) expansion carriers had a similar cognitive profile to those with the more common CAG(40-42) expansions. These individuals may evade molecular diagnosis because of the absence of chorea rather than because of a low penetrance of symptoms. This finding should encourage neurologists to consider Huntington's disease in cognitively impaired elderly patients without typical chorea and anticipate consequences for genetic counseling in their offspring. (c) 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
引用
收藏
页码:1294 / 1306
页数:13
相关论文
共 50 条
  • [21] The Role of CAG Repeat Size and Parental Sex in Huntington's Disease
    Keller, Eric
    McCormack, Michael
    Hillen, Machteld
    NEUROTHERAPEUTICS, 2018, 15 (01) : 250 - 251
  • [22] Age, CAG repeat length, and clinical progression in Huntington's disease
    Rosenblatt, Adam
    Kumar, Brahma V.
    Mo, Alisa
    Welsh, Claire S.
    Margolis, Russell L.
    Ross, Christopher A.
    MOVEMENT DISORDERS, 2012, 27 (02) : 272 - 276
  • [23] Is the progression of Huntington's disease determined by somatic CAG repeat instability?
    Vatsavayai, SC
    Dallérac, GM
    Milner, AJ
    Cummings, DM
    Murphy, KPSJ
    Hirst, MC
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [24] The relationship between CAG repeat length and progression in Huntington's disease
    Ravina, Bernard
    Romer, Megan
    Constantinescu, Radu
    Biglan, Kevin
    Kieburtz, Karl
    Shoulson, Ira
    McDermott, Michael
    ANNALS OF NEUROLOGY, 2007, 62 : S40 - S40
  • [25] The effects of CAG repeat length on clinical progression in Huntington's disease
    Rosenblatt, A
    Abbott, MH
    Gourley, LM
    Margolis, RL
    Brandt, J
    Ross, CA
    Liang, KY
    Zhou, H
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [26] Linking SNPs to CAG repeat length in Huntington's disease patients
    Liu, Wanzhao
    Kennington, Lori A.
    Rosas, H. Diana
    Hersch, Steven
    Cha, Jang-Ho
    Zamore, Phillip D.
    Aronin, Neil
    NATURE METHODS, 2008, 5 (11) : 951 - 953
  • [27] Late onset Huntington's disease with 29 CAG repeat expansion
    Garcia-Ruiz, Pedro J.
    Garcia-Caldentey, Juan
    Feliz, Cici
    del Val, Javier
    Herranz, Antonio
    Carlos Martinez-Castrillo, Juan
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 363 : 114 - 115
  • [28] Effect of CAG repeat length on psychiatric disorders in Huntington's disease
    Vassos, Evangelos
    Panas, Marios
    Kladi, Athina
    Vassilopoulos, Dimitrios
    JOURNAL OF PSYCHIATRIC RESEARCH, 2008, 42 (07) : 544 - 549
  • [29] DNA polymerase θ promotes CAG•CTG repeat expansions in Huntington's disease via insertion sequences of its catalytic domain
    Chan, Kara Y.
    Li, Xueying
    Ortega, Janice
    Gu, Liya
    Li, Guo-Min
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (04)
  • [30] CAG Repeat Length and Suicidality in Huntington Disease.
    Kutz, C.
    NEUROTHERAPEUTICS, 2016, 13 (01) : 255 - 256